Zota Health Care vs Peers
- Market cap
- ₹4,592 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹954.65 – ₹1,789.97
Zota Health Care ranks 1st by market capitalisation among 1 Biotechnology companies tracked by ATS. Its largest peers are Zota Health Care. Its P/E of 22.5 compares with a peer median of 22.5.
Zota Health Care vs Biotechnology peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Zota Health Care | 1,325.90 | +0.26% | 4,592 | 22.5 | 2.85 | 14.5% | +18.5% |
| Zota Health Care | 1,325.90 | +0.26% | 4,592 | 22.5 | 2.85 | 14.5% | +24.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 9 October 2026. How this data is compiled.
Zota Health Care peer comparison — frequently asked questions
Who are Zota Health Care's competitors?
Zota Health Care's listed peers in Biotechnology include Zota Health Care, ranked here by market capitalisation.
How does Zota Health Care's P/E compare with its peers?
Zota Health Care trades at a P/E of 22.5, against a median of 22.5 across the 1 Biotechnology peers shown.
Which is the largest company among Zota Health Care's peers?
By market capitalisation, the largest company in the group is Zota Health Care at ₹4,592 crore, against ₹4,592 crore for Zota Health Care.
Same Data For Peers
Trade Zota Health Care With ATS
Track ZOTA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.